Santos Dumont Institute
Macaíba, Rio Grande do Norte, 59288-999, Brazil
NCT Number: NCT07768930
This study aims to investigate the effectiveness of Brain-Computer Interface (BCI)-guided Functional Electrical Stimulation (FES) in improving muscle activation and gait kinematics in individuals with Spinal Cord Injury (SCI).
This study is active but is not currently recruiting participants.
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Macaíba, Rio Grande do Norte, 59288-999, Brazil
Introduction:
Spinal Cord Injury (SCI) causes serious motor and sensory deficits, affecting thousands of people globally. Brain-Computer Interface (BCI) combined with Functional Electrical Stimulation (FES) emerges as a promising strategy to rehabilitate individuals with SCI. This mechanism will simultaneously stimulate the affected regions of the lower limbs, causing the compromised muscles to contract, causing movement. The FES technique, with its proven effectiveness in improving muscle strength, stands out as a crucial resource in this process of improving approaches integrated with advanced technology and physiotherapeutic principles to offer a promising perspective in neuromuscular rehabilitation.
Objective:
This study aims to investigate the effectiveness of Brain-Computer Interface (BCI)-guided Functional Electrical Stimulation (FES) in improving muscle activation and gait kinematics in individuals with Spinal Cord Injury (SCI).
Methodology:
This is a quasi-experimental study that will be conducted with four (n=4) volunteers with Spinal Cord Injury (age range: 18-60 years), of both sexes. Data collection will take place at the Edmond and Lily Safra International Institute of Neurosciences (IIN-ELS), Macaíba/RN, Brazil. For the characterization and eligibility of volunteers, the following instruments will be used: Modified Ashworth Scale, Douleur Neuropathique 4 questionnaire (DN4), and the Visual-10, Kinesthetic and Visual Imagery Questionnaire-10 (KVIQ-10). For clinical outcomes, the American Spinal Injury Association (ASIA), Spinal Cord Independence Measure - version III (SCIM-III), and the World Health Organization Quality of Life (WHOQOL-BREF) will be used. At the end of the protocol, the following questionnaires will be administered: System Usability Scale (SUS), Intrinsic Motivation Inventory (IMI), and Task Load Index (NASA-TLX) to assess system usability, intrinsic motivation, and perceived workload. The intervention will consist of 24 sessions aiming to use a brain-computer interface based on kinesthetic motor imagery of dorsiflexion associated with neurofeedback (visual and tactile), focused on the functional outcomes of individuals with paraplegia. During the intervention, volunteers will be instructed to imagine performing the dorsiflexion movement. An electroencephalogram (EEG) will be used to monitor brain activity through sensorimotor rhythms. When activity reaches a minimum threshold, functional electrical stimulation (FES) will be triggered, causing contraction of the tibialis anterior muscle.
Expected Results:
It is expected that BCI-guided FES targeting tibialis anterior muscle activation in individuals with SCI will contribute to the rehabilitation process by promoting improvements in neurological function, functional independence, and cortical activity. Changes are expected in clinical outcomes assessed by the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI/ASIA) and the Spinal Cord Independence Measure III (SCIM III), as well as in EEG patterns associated with sensorimotor cortical activation. Furthermore, this innovative approach will not only provide improvements in the physical performance of individuals with SCI, but will also contribute to the continuous evolution of rehabilitation strategies, highlighting the fundamental role of technological advances in promoting the quality of life and autonomy of these individuals.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention protocol will last 26 min. The first 2 min are used to collect EEG data under baseline conditions, during which the participant does not perform mental tasks or receive electrical stimulation. Then there is 6 min of motor training with Neurofeedback (NFB). During this time, two 10s periods: one in which the FES devices are activated without motor imagery (MI), and another in which the FES is activated by the MI to induce movements in the feet. This includes six separate attempts for the right foot, left foot, and both feet, for a total of 18 attempts. After completing the NFB phase, the participant rests for 6 min to avoid mental and muscular fatigue.
Subsequently, the user performs 12 min of training with BCI. This involves 20s intervals of MI to trigger the FES devices to dorsiflex the feet, followed by 20s rest periods. This cycle is repeated for a total of 18 exercises, six for each movement (right foot, left foot and both feet).
Other names: Motor imagery, Brain - Computer Interface, Neurofeedback, Functional electrical stimulation
Time frame: Baseline (before start of the intervention) At 12 week after baseline At 24 week after baseline
The International Standards for Neurological Classification of Spinal Cord Injury/ASIA will be used to assess the neurological level and severity of spinal cord injury, including motor and sensory function. The sensory score ranges from 0 (absent) to 2 (normal). The ASIA sensory scores for light touch and pinprick are calculated by summing the scores across 28 dermatomes, with a total score ranging from 0 to 112 for each modality. Higher scores indicate better sensory function. Motor function will be assessed bilaterally using the 10 key muscles corresponding to the C5-T1 and L2-S1 myotomes. Muscle strength is graded from 0 (total paralysis) to 5 (normal movement against maximum resistance). The ASIA Lower Extremity Motor Score (LEMS; range 0-50) will be used to assess lower-extremity motor function, with higher scores indicating better motor function.
Time frame: Baseline (before start of the intervention) At 12 week after baseline At 24 week after baseline
To assess functional independence in individuals with spinal cord injury. The instrument evaluates self-care, respiration and sphincter management, and mobility. The total Spinal Cord Independence Measure III score ranges from 0 to 100, with higher scores indicating greater levels of independence.
Time frame: Baseline (before start of the intervention); At 24 week after baseline.
Verify the clinical effects and cortical activity of mu and beta rhythms through electroencephalography analysis. Power Spectral Density (PSD) will be estimated using Welch's periodogram. Mean power will be calculated across trials for the mu (8-12 Hz) and beta (18-24 Hz) frequency bands. Power values will then be normalized to the mean power across the 8-30 Hz passband. The percentage change in power during kinesthetic motor imagery relative to the resting condition will then be calculated.
Time frame: At 24 week after baseline.
To evaluate participants' perception and satisfaction in relation to the intervention protocol, using the System Usability Scale questionnaire, with the aim of identifying the most relevant and impactful aspects of the intervention for volunteers with SCI. The final score ranges from 0 to 100, with scores above 68 indicating good system usability.
Time frame: Baseline (before start of the intervention); At 12 week after baseline; At 24 week after baseline
The World Health Organization Quality of Life-BREF will be used to assess participants' perceived quality of life. The questionnaire evaluates four domains: physical health, psychological health, social relationships, and environment. The raw domain score will be converted into a standardized score, ranging from 0 to 100, with a higher score indicating a better perceived quality of life.
Time frame: At 24 week after baseline
The Task Load Index will be used to assess participants' perceived workload during the intervention. The questionnaire evaluates six dimensions: mental demand, physical demand, temporal demand, performance, effort, and frustration. The sum of the weighted mean scores across these dimensions results in a total perceived workload score ranging from 0 to 100, classified as very low (0-20), low (21-40), moderate (41-60), high (61-80), and very high (81-100). Higher scores indicate greater perceived workload.
Time frame: At 24 week after baseline.
It consists of 10 items rated on a 7-point Likert scale, ranging from 1 to 7, with higher scores indicating greater motivation and reflecting the level of agreement or satisfaction regarding different aspects of the motivational experience. The domains assessed include interest/enjoyment, effort/importance, and value/usefulness.
Time frame: Baseline (before start of the intervention).
To identify the presence of neuropathic pain. The score ranges from 0 to 10, with scores ≥4 indicating the presence of neuropathic pain. For the eligibility criteria.
Time frame: Baseline (before start of the intervention).
To assess the volunteer's ability to generate and manipulate mental images. The questionnaire score ranges from 0 to 25, with higher scores indicating greater motor imagery ability.. For the eligibility criteria.
Time frame: Baseline (before start of the intervention).
To assess muscle spasticity, with scores ranging from 0 to 4, where 0 indicates no increase in muscle tone and 4 indicates severe spasticity, for eligibility assessment.
Santos Dumont Institute
Other
Use of Brain Interface-Guided Functional Electrical Stimulation - Gait Training Machine in Individuals With Spinal Cord Injury
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05921487
Body Weight, Central Nervous System Diseases
Syracuse, New York, United States
View Trial DetailsNCT07550699
Acquired Brain Injury (Including Stroke), Autoimmune Diseases
Vienna, State of Vienna, Austria
View Trial DetailsNCT07739134
ALS, Brain Damage, Chronic
Zurich, Canton of Zurich, Switzerland
View Trial DetailsNCT02632422
Central Nervous System Diseases, Nervous System Diseases
Atlanta, Georgia, United States
View Trial Details